Boehringer Ingelheim is a global, research-driven pharmaceutical company embracing many cultures and diverse societies.
[img][/img]
From initial discovery to a marketable medicine is a long, challenging road. Our new discovery research strategy aims at enhancing our capacity for innovation and at encouraging scientific creativity for diseases with high unmet medical need. Read more about Dr Paola Casarosa and her work on developing therapeutic alliances and strategic partnerships. As a research-driven pharmaceutical company Boehringer Ingelheim strives to improve health of people and animals everywhere in the world.
